CRL · 10-Q · 2026Q2 · Full report

Headcount / Restructuring

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 64 · Surprise 42

The company is implementing workforce right-sizing, site optimization, process improvements, procurement synergies, and a global business services model in response to demand conditions. These initiatives are expected to generate approximately $300 million of cumulative annualized cost savings by the end of 2026, including more than $175 million realized in fiscal 2025. Restructuring charges were $23.1 million in the second quarter and $54.6 million in the first six months of 2026, including severance, asset impairments, accelerated depreciation, and site-consolidation costs.

Key facts